Aesthetic Nurse Software Secures £10k Pre-Seed Funding to Digitise Independent Clinics

Birmingham-based HealthTech startup Aesthetic Nurse Software Limited has successfully raised £10k in a pre-seed funding round. The investment brings the company to a post-money valuation of £20k and will support the continued development of its paperless clinic management platform, which is tailored specifically for aesthetic practitioners.

Founded in October 2016 by aesthetic nurse Jo Hayward, Aesthetic Nurse Software addresses the heavy administrative burden faced by independent clinics. Managing an aesthetics practice often involves juggling multiple systems for diaries, patient communication, and clinical compliance. The platform transitions practitioners, including nurses, doctors, and dentists, away from cumbersome paper records to a secure, cloud-based digital system.

The software provides a centralised hub for managing appointment bookings, digital patient questionnaires, consent forms, treatment notes, prescriptions, and clinical photography. This ensures that every part of the patient journey is stored safely in one place. Operating out of Birmingham, the B2B software company currently employs a team of between seven and 12 staff members. By offering an intuitive and affordable system that is accessible across any device, the company enables clinics to maintain compliant, well-structured records while delivering a seamless patient experience. Revenue and profit metrics remain undisclosed at this stage of the company's growth.

The pre-seed round saw £10k raised at an estimated post-money valuation of £20k. The allotment date for the shares was 1 March 2026, with the official filing completed today, 17 March 2026. While specific investors were not named in the filing, the capital injection marks a formal step in the company's equity journey as it scales its software solutions for the aesthetics industry. Because this is an early stage pre-seed transaction, there are no previous institutional funding rounds on record to compare against.

This funding aligns with broader trends in the United Kingdom's thriving software and HealthTech sectors. Recent market data indicates that the domestic SaaS market is projected to reach a combined value of £1.2 trillion, with venture capital activity continuing to outpace other European markets. In early 2025, UK venture capital deal value held steady at £4.4 billion for the first quarter, with healthcare and software emerging as key drivers of investment activity. For niche B2B platforms like Aesthetic Nurse Software, the focus on automation, compliance, and data management positions them well within a domestic ecosystem that heavily rewards vertical specialisation and digital transformation in the medical and aesthetic fields.